Table 1 Baseline characteristics of the MPM TMA samples.

From: Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment

Age, median (IQR)

67 (60.2–72)

Stage after neoadjuvant therapy

 I

38

 II

2

 III

32

 IV

2

 Histology

 

 Epithelial

66

 Sarcomatoid

8

 Biphasic

20

 Not specified

4

Back to article page